1. medication may be beneficial (Priotto et al., 2009). Berry, 1989). When compared with the current first-line therapy, co-The results of this combination trial will likely significantly alter the trimoxazole (see Chapter 83, Trimethoprim, Co-Trimoxazole (Co-T)
2. arranged on a bifunctional protein (Muller et al., 2008). Although (Blume-Peytavi and Hahn, 2008).
3. Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis.
4. Polyamine Metabolism: A Potential Therapeutic Target in Trypanosomes